These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20173019)

  • 1. Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.
    Boldarine VT; Maciel RM; Guimarães GS; Nakabashi CC; Camacho CP; Andreoni DM; Mamone Mda C; Ikejiri ES; Kasamatsu TS; Crispim F; Hojaij FC; Hidal JT; Biscolla RP
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1726-33. PubMed ID: 20173019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
    Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
    Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
    Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
    Eszlinger M; Neumann S; Otto L; Paschke R
    Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study.
    Bellantone R; Lombardi CP; Bossola M; Ferrante A; Princi P; Boscherini M; Maussier L; Salvatori M; Rufini V; Reale F; Romano L; Tallini G; Zelano G; Pontecorvi A
    Cancer; 2001 Nov; 92(9):2273-9. PubMed ID: 11745281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
    Biscolla RP; Cerutti JM; Maciel RM
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients.
    Savagner F; Rodien P; Reynier P; Rohmer V; Bigorgne JC; Malthiery Y
    J Clin Endocrinol Metab; 2002 Feb; 87(2):635-9. PubMed ID: 11836297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.